Sandoz enters agreement to develop non-opioid pain relief

10-05-2017

Sandoz enters agreement to develop non-opioid pain relief

solidcolours / iStockphoto.com

Sandoz has entered into a development and commercialisation agreement with pharmaceutical company Durect to develop the drug Posimir (Saber-bupivacaine).


Sandoz, Durect, agreement, m&a, development, commercialisation, Posimir, pain relief

LSIPR